Opportunities and challenges following approval of resmetirom for MASH liver disease

作者：Jeffrey V. Lazarus, Dana Ivancovsky‐Wajcman, Henry E. Mark, Zobair M. Younossi, Christopher J. Kopka, Nevin Cohen, Meena B. Bansal, Michael Betel, Paul Brennan · 发表于：Nature Medicine · 年份：2024 · DOI：10.1038/s41591-024-02958-z · 被引用次数：59 · 研究领域：Liver Disease Diagnosis and Treatment、Diet and metabolism studies、Metabolism, Diabetes, and Cancer